Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
about
Infectivity of blood components with low hepatitis B virus DNA levels identified in a lookback program.Occult hepatitis B virus infection and blood transfusionPre- and post-transfusion testing for hepatitis B virus surface antigen and antibody in blood recipients: a single-institution experience in an area of high endemicity.Reducing the risk of hepatitis B virus transfusion-transmitted infectionHBsAg level and hepatitis B viral load correlation with focus on pregnancyA comprehensive serological and supplemental evaluation of hepatitis B "seroyield" blood donors: A cross-sectional study from a tertiary healthcare center in India.The National Heart, Lung, and Blood Institute retrovirus epidemiology donor studies (Retrovirus Epidemiology Donor Study and Retrovirus Epidemiology Donor Study-II): twenty years of research to advance blood product safety and availability.New strategies for blood donor screening for hepatitis B virus: nucleic acid testing versus immunoassay methods.Hepatitis B virus blood screening: unfinished agendas.Hepatitis B surface antigen levels: association with 5-year response to peginterferon alfa-2a in hepatitis B e-antigen-negative patients.Deficiencies in the standardization and sensitivity of diagnostic tests for hepatitis B virus.Inhibition of hepatitis B virus (HBV) gene expression and replication by HBx gene silencing in a hydrodynamic injection mouse model with a new clone of HBV genotype B.Development of a highly sensitive bioluminescent enzyme immunoassay for hepatitis B virus surface antigen capable of detecting divergent mutants.Hepatitis B virus infection and transfusion medicine: science and the occult.The correlation between serum HBsAg levels and viral loads depends upon wild-type and mutated HBV sequences rather than the HBeAg/anti-HBe status.Hepatitis B virus DNA and hepatitis B surface antigen levels in chronic hepatitis B.Quantification of HBsAg: basic virology for clinical practiceMolecular mechanisms underlying HBsAg negativity in occult HBV infection.Hepatitis B surface antigen: association with sustained response to peginterferon alfa-2a in hepatitis B e antigen-positive patients.Evaluation of algorithms for the diagnostic assessment and the reentry of blood donors who tested reactive for antibodies against hepatitis B core antigen.Cost-effectiveness of quantitative hepatitis B virus surface antigen testing in pregnancy in predicting vertical transmission risk.Development of cost-effective real-time PCR test: to detect a wide range of HBV DNA concentrations in the western Amazon region of Brazil.Hepatitis B surface antigen levels after hepatitis B e-antigen seroclearance: a longitudinal follow-up study.Procleix Ultrio transcription-mediated amplification vs. serological blood screening in south-western Greece.A pilot study for screening blood donors in Taiwan by nucleic acid amplification technology: detecting occult hepatitis B virus infections and closing the serologic window period for hepatitis C virus.Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003.Detection of occult hepatitis C and hepatitis B virus infections from peripheral blood mononuclear cells.Evaluation of COBAS AmpliPrep nucleic acid extraction in conjunction with COBAS AmpliScreen HBV DNA, HCV RNA and HIV-1 RNA amplification and detection.Comparison of two automated nucleic acid testing systems for simultaneous detection of human immunodeficiency virus and hepatitis C virus RNA and hepatitis B virus DNA.Evaluation of a multiplex human immunodeficiency virus-1, hepatitis C virus, and hepatitis B virus nucleic acid testing assay to detect viremic blood donors in northern Thailand.Diversity of hepatitis B virus infecting Malaysian candidate blood donors is driven by viral and host factors.A large case-control study on the predictability of hepatitis B surface antigen levels three years before hepatitis B surface antigen seroclearance.Serum hepatitis B surface antigen and hepatitis B e antigen titers: disease phase influences correlation with viral load and intrahepatic hepatitis B virus markers.Detection and characterization of hepatitis B virus of anti-hepatitis B core antigen-reactive blood donors in Quebec with an in-house nucleic acid testing assay.Sensitivity of hepatitis B virus DNA transcription-mediated amplification testing in hepatitis B surface antigen-positive blood donations.Lack of correlation between hepatitis B surface antigen and hepatitis B virus DNA levels in blood donors.Hepatitis B Virus Blood Screening: Need for Reappraisal of Blood Safety Measures?Stability of hepatitis B surface antigen over time: Implications for studies using stored seraResidual Risk of Hepatitis-B-Infected Blood Donations: Estimation Methods and Perspectives
P2860
Q33288333-D4AB4839-0EAD-49A4-ACBC-34ABFF992980Q35237335-352C7FD3-C03A-4076-865E-536715B72AE7Q35664869-3D762050-0FF9-478A-8C6B-5ED15AA79D9AQ35683881-15128456-C7BA-4935-A237-95F7AED4AB82Q35779493-AADD5FBE-EDCA-4EB5-8E41-F393026C0095Q36034889-0592C849-CE7D-48B1-87D3-6F06E2125123Q36252455-498C44CE-1FC1-4211-8369-37EC93B9E167Q36466447-067DED45-2DDB-4139-83CA-0148E8979C4DQ36498410-3ED89350-67D4-458B-B179-C7F0119C261FQ36695222-2170263C-26E1-408D-A350-778E126C6102Q36980710-E04A2AD3-A090-45A8-96EF-24533431899CQ37116860-7799563A-F46F-4931-BCC4-44649F6C4D3CQ37124701-81055DFD-1340-4953-8A6D-8A75FA25321AQ37153782-F450F366-3495-47C3-B1D0-F3EF59511DFFQ37166945-2934A94C-1E71-4B92-B5A1-32057CDDD8B0Q37762545-27EA5BDB-EA5B-4BEB-BF4D-AEF6AC71CB26Q37831142-5E7BEB5B-B0B7-4CBE-A138-BBBC7C1727F3Q38536404-87809DC4-F1CF-48C3-982C-13AD10108D0FQ39736089-57CF6690-8063-4AF3-BB27-B5DD0CA2A3EFQ39788643-298A9376-87F2-4938-970F-4CF5D9A6633BQ40722693-80E530B9-7A51-474F-872C-9922A6ED715AQ41900242-E780D964-A852-44FA-AAB5-A49350BB7A53Q42217913-BBEE3A08-4085-4670-80D0-0726E353B76EQ42977683-3271E4B3-047A-4CF4-8728-612C5519AB73Q42977855-F376488A-D264-4FAE-91ED-7617CF900B49Q42992279-817E157C-888D-4F30-A248-CC16B3139B39Q42996222-B1487D40-BF5F-4CB9-94BE-55A7F80B453CQ42996377-0DD9E154-7D1A-437A-9F87-9950328D9BB8Q43040836-9AA96DFE-6F4F-4E78-BCBB-F8A036C81BC3Q43040840-4B305E6B-FF74-4CF6-B66B-B6B888DE0E99Q44599757-1A263E78-6599-4480-93F1-4478C24842B1Q44766209-B416FD32-0450-49B5-93FD-56E845BDD134Q45375655-DC3CE654-7B2C-4CB1-A1EB-85CD1272CA08Q45400011-72C74C7B-2825-4230-8B46-E7D7FACDBC91Q45409042-E3788703-A6BE-4377-A50C-2C69C2DE24C0Q45453767-D75A2EB6-40D6-410C-8997-B432912E702AQ51743195-4E5C80D3-0A26-48FA-AE7C-20F6AEB0D2A0Q58235845-D03E17AA-9F0A-43DB-8D8B-CDD9BCE0D397Q58999805-339F6DE8-663E-40AB-B311-20AB4D26DB75
P2860
Lack of correlation between HBsAg and HBV DNA levels in blood donors who test positive for HBsAg and anti-HBc: implications for future HBV screening policy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Lack of correlation between HB ...... r future HBV screening policy.
@en
type
label
Lack of correlation between HB ...... r future HBV screening policy.
@en
prefLabel
Lack of correlation between HB ...... r future HBV screening policy.
@en
P2093
P2860
P1433
P1476
Lack of correlation between HB ...... r future HBV screening policy.
@en
P2093
Anne L McNamara
Bhupat Rawal
Mary C Kuhns
REDS Study Group
Simone Glynn
Steven H Kleinman
P2860
P304
P356
10.1111/J.1537-2995.2004.04055.X
P577
2004-09-01T00:00:00Z